Ovarian cancer treatment: late-stage pipeline partnerships
JCI Insight - Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer
Treatment of epithelial ovarian cancer | The BMJ
Recurrent Epithelial Ovarian Cancer: An Update on Treatment
Breast and Ovarian Cancer Clinical Trials
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo- controlled, phase 2b trial - The Lancet Oncology
JCI Insight - Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer
Promising treatment for ovarian cancer reaches final stages of clinical trials
Advances in ovarian cancer, from biology to treatment | Nature Cancer
Chemotherapy of ovarian cancer (Chapter 26) - Altchek's Diagnosis and Management of Ovarian Disorders
BEVACIZUMAB IN OVARIAN CANCER -Clinical Trials Ongoing | Download Table
Ovarian Cancer | Symptoms, Diagnosis & Treatment | MD Anderson Cancer Center
Mucinous Ovarian Carcinoma | NEJM
Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer patients treated with primary or interval cytoreductive surgery -
Upcoming Clinical Trials for Ovarian Cancer
Emerging Immunotherapeutics for Ovarian Cancer Symposium - The Antibody Society
Tools in the pharmacologic arsenal for treatment of ovarian cancer.... | Download Scientific Diagram
Clinical trials results for PARP Inhibitors in ovarian cancer. | Download Table
Ovarian Cancer | Patient Care
![PDF] Current and future directions of clinical trials for ovarian cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7f15aa00fe070d53cbd782ae6153a6a322dec4f1/4-Figure2-1.png "PDF] Current and future directions of clinical trials for ovarian cancer. | Semantic Scholar")
PDF] Current and future directions of clinical trials for ovarian cancer. | Semantic Scholar
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor - Gynecologic
BEVACIZUMAB IN OVARIAN CANCER: Phase III Trial -Clinical Trials Ongoing | Download Table
Fact Sheet Ovarian Cancer Clinical Trial - BioCanRx
PARP inhibitors in ovarian cancer - Cancer Treatment Reviews
